Donepezil not associated with increased risk of proarrhythmic cardiac eventsResearchers say the finding could also help ease administrative burden for those prescribing this common medication for dementia. Diltiazem increases bleeding risk in older adults receiving apixaban or rivaroxaban Diltiazem used for ventricular rate control in patients with atrial fibrillation inhibits apixaban and rivaroxaban elimination, possibly causing overanticoagulation. POP QUIZ: Insomnia in youth Which statement would NOT be good advice for managing insomnia in an adolescent? Can oral minoxidil be used instead of topical minoxidil for male pattern baldness? A 24-week randomized clinical trial compares low-dose oral minoxidil and topical minoxidil solution for male androgenetic alopecia. Can ketamine treat substance use disorders? A CADTH review looks into the evidence amid increased interest in using ketamine to treat mental illnesses. Rimegepant (Nurtec ODT) now available for acute treatment of migraine Rimegepant is the second oral “gepant” for acute migraine to be marketed in Canada following ubrogepant (Ubrelvy). Drug news—April 2024 A review of new launches, new indications, new dosage forms and Health Canada advisories. Many cancer drugs remain unproven 5 years after accelerated U.S. FDA approval, a study finds The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives? Taking a stab at HIV The advent of long-acting antiretroviral therapies for HIV suppression and prevention. Most federal supply of Paxlovid will expire on March 31, Ontario, B.C. tell pharmacists The rest of the supplies will expire on May 31. First Previous 34 35 36 37 38 Next Last
